跳到主要导航 跳到搜索 跳到主要内容

Folic Acid–Functionalized Metal-Organic Framework Nanoparticles as Drug Carriers Improved Bufalin Antitumor Activity Against Breast Cancer

  • Hairong Zeng
  • , Chao Xia
  • , Bei Zhao
  • , Mengmeng Zhu
  • , Hao Yue Zhang
  • , Die Zhang
  • , Xin Rui*
  • , Huili Li*
  • , Yi Yuan*
  • *此作品的通讯作者
  • Shanghai University of Traditional Chinese Medicine
  • East China Normal University
  • Nanjing University of Chinese Medicine
  • Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine

科研成果: 期刊稿件 › 文章 › 同行评审

摘要

Bufalin (Buf), an active ingredient of the traditional Chinese medicine Chansu, is known to have anticancer effects for breast cancer. However, its poor solubility, high toxicity, and extensive side effects limit its use. Metal-organic frameworks (MOFs) are a class of promising drug delivery systems known for their high porosity. Here, we designed and constructed pH-sensitive and redox-responsive folic acid–modified MOFs as drug carriers of Buf (FA-MOF/Buf). Moreover, the anticancer activity of nanomedicines was also explored in vitro and in vivo. Compared to free Buf, the FA-MOF/Buf nanoparticles demonstrated improved water solubility and stability, higher intracellular uptake, and enhanced cytotoxicity in breast cancer cells in vitro. Furthermore, it displayed improved accumulation in the tumor site, enhanced anticancer activity, and reduced side effects in vivo. Our results demonstrated that FA-MOF could be developed as a potential delivery system for Buf to improve its antitumor activity for breast cancer treatment.

源语言英语
期刊论文编号747992
期刊Frontiers in Pharmacology
卷12
DOI
出版状态已出版 - 18 1月 2022

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'Folic Acid–Functionalized Metal-Organic Framework Nanoparticles as Drug Carriers Improved Bufalin Antitumor Activity Against Breast Cancer' 的科研主题。它们共同构成独一无二的学术指纹。

引用此